Compound Evidence File
#EC-2026-0966
Lipo-C 120mg
Filed under Injectable Oils. The bureau holds 140 laboratory returns for this compound from 52 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
52 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 6 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 9.9 | 10.0 | 20 Apr 2026 | 7 Jul 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 10.0 | 9.9 | 10.0 | 23 Feb 2026 | 10 Aug 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 10.0 | 10.0 | 10.0 | 16 May 2026 | 6 Aug 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 10.0 | 9.9 | 10.0 | 12 Mar 2026 | 10 Aug 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 10.0 | 9.9 | 10.0 | 21 Feb 2026 | 3 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 9.9 | 10.0 | 5 Jan 2026 | 9 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 10.0 | 10.0 | 11 Mar 2026 | 19 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 10.0 | 10.0 | 10.0 | 5 Jun 2026 | 2 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 10.0 | 10.0 | 10.0 | 23 Dec 2025 | 11 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 10.0 | 10.0 | 10.0 | 9 Jan 2026 | 9 Apr 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 10.0 | 10.0 | 10.0 | 10 Apr 2026 | 6 Jul 2026 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 10.0 | 10.0 | 10.0 | 25 Apr 2025 | 25 Apr 2025 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 9.9 | 9.9 | 10.0 | 15 Feb 2026 | 2 May 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 9.9 | 9.9 | 10.0 | 15 Jun 2026 | 8 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 9.9 | 9.9 | 9.9 | 4 Jan 2026 | 6 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 9.9 | 9.9 | 10.0 | 5 Mar 2026 | 27 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 9.9 | 9.9 | 10.0 | 1 Apr 2026 | 2 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 9.9 | 9.9 | 9.9 | 15 Apr 2026 | 1 Aug 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 9.9 | 9.9 | 10.0 | 22 Jun 2026 | 7 Aug 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 9.9 | 9.9 | 10.0 | 10 Feb 2026 | 1 May 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 9.9 | 9.9 | 10.0 | 1 Mar 2026 | 17 May 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 4 Jun 2026 | 13 Jun 2026 |
| Pura PeptidesCASE #VI-2026-0307 | X | 1 | 9.5 | 9.5 | 9.5 | 16 Mar 2025 | 16 Mar 2025 |
| Aavant ResearchCASE #VI-2026-0831 | X | 1 | 9.3 | 9.3 | 9.3 | 3 Jun 2025 | 3 Jun 2025 |
| Amino LairCASE #VI-2026-0413 | X | 1 | 9.0 | 9.0 | 9.0 | 25 Apr 2025 | 25 Apr 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 8 | 8.8 | 7.1 | 10.0 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 2 | 8.8 | 7.7 | 10.0 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 8 | 8.7 | 7.6 | 9.7 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 7 | 8.1 | 6.4 | 10.0 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 4 | 8.0 | 6.4 | 9.5 | 24 May 2026 | 24 May 2026 |
| OmegAminoCASE #VI-2026-0014 | X | 1 | 7.9 | 7.9 | 7.9 | 17 Dec 2024 | 17 Dec 2024 |
| Huaian Hanyou PeptideCASE #VI-2026-0297 | X | 1 | 7.9 | 7.9 | 7.9 | 2 Jul 2025 | 2 Jul 2025 |
| Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433 | X | 1 | 7.5 | 7.5 | 7.5 | 13 Feb 2025 | 13 Feb 2025 |
| AKS ChemCASE #VI-2026-0313 | X | 1 | 7.2 | 7.2 | 7.2 | 21 May 2025 | 21 May 2025 |
| Peptide-SCASE #VI-2026-0111 | X | 5 | 7.1 | 6.5 | 7.7 | 8 Jul 2025 | 19 Jan 2026 |
| NextechLabsCASE #VI-2026-0285 | X | 1 | 7.1 | 7.1 | 7.1 | 24 Apr 2025 | 24 Apr 2025 |
| HazelCASE #VI-2026-0392 | X | 1 | 7.1 | 7.1 | 7.1 | 9 Jun 2025 | 9 Jun 2025 |
| Zenith Jove Peptide ZJCASE #VI-2026-0570 | X | 2 | 6.7 | 6.3 | 7.1 | 6 May 2025 | 26 Jan 2026 |
| Xingtai Lesda TechnologyCASE #VI-2026-0381 | X | 1 | 6.6 | 6.6 | 6.6 | 13 Feb 2025 | 13 Feb 2025 |
| Henan Sahe PeptideCASE #VI-2026-0894 | X | 1 | 6.4 | 6.4 | 6.4 | 27 Feb 2025 | 27 Feb 2025 |
| Zztai PeptideCASE #VI-2026-0192 | X | 1 | 6.3 | 6.3 | 6.3 | 17 Dec 2024 | 17 Dec 2024 |
| Astro PeptidesCASE #VI-2026-0424 | X | 2 | 6.2 | 5.0 | 7.5 | 13 Jun 2025 | 21 May 2026 |
| Amino AsylumCASE #VI-2026-0828 | X | 1 | 6.2 | 6.2 | 6.2 | 13 Feb 2025 | 13 Feb 2025 |
| CellupepCASE #VI-2026-0888 | X | 1 | 5.4 | 5.4 | 5.4 | 14 Jan 2025 | 14 Jan 2025 |
| Shanghai OuDaXin New Material Technology CenterCASE #VI-2026-0498 | E | 4 | 5.3 | 2.5 | 7.5 | 13 Feb 2025 | 21 May 2026 |
| Liberty PeptidesCASE #VI-2026-0416 | X | 1 | 5.2 | 5.2 | 5.2 | 17 Dec 2024 | 17 Dec 2024 |
| Limitless Life NootropicsCASE #VI-2026-0980 | X | 2 | 4.2 | 3.3 | 5.1 | 11 Jun 2025 | 17 May 2026 |
| DeuschemCASE #VI-2026-0004 | X | 2 | 4.0 | 3.9 | 4.2 | 8 Jul 2025 | 19 Jan 2026 |
| Zhuoyue BiotechnologyCASE #VI-2026-0632 | X | 1 | 2.9 | 2.9 | 2.9 | 13 Feb 2025 | 13 Feb 2025 |
| NuLife PeptidesCASE #VI-2026-0980 | X | 1 | 0.0 | 0.0 | 0.0 | 8 Jul 2025 | 8 Jul 2025 |
Open any subject to view the batch-level evidence for Lipo-C 120mg alone.